Researchers are hopeful for the next round of the study since tofacitinib shows potential in those with scleroderma
It affects 100,000 persons in the US alone. Scleroderma, also known as systemic sclerosis, is a group of rare diseases that involve the hardening and tightening of the skin. It may also cause problems in the blood vessels, internal organs and digestive tract. Scleroderma, also known as systemic sclerosis, is one of the rarest autoimmune […]
